RG
IBRX icon

Rathbones Group’s ImmunityBio IBRX Stock Holding History

Rathbones Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Sell
153,420
-8,000
-5% -$54.8K ﹤0.01% 342
2025
Q4 		$320K Hold
161,420
– – ﹤0.01% 511
2025
Q3 		$397K Buy
161,420
+44,000
+37% +$113K ﹤0.01% 473
2025
Q2 		$310K Buy
117,420
+20,800
+22% +$55.9K ﹤0.01% 496
2025
Q1 		$291K Buy
96,620
+7,200
+8% +$21.8K ﹤0.01% 466
2024
Q4 		$229K Buy
89,420
+16,000
+22% +$66.7K ﹤0.01% 509
2024
Q3 		$273K Hold
73,420
– – ﹤0.01% 500
2024
Q2 		$464K Hold
73,420
– – ﹤0.01% 423
2024
Q1 		$394K Hold
73,420
– – ﹤0.01% 448
2023
Q4 		$369K Hold
73,420
– – ﹤0.01% 446
2023
Q3 		$124K Buy
+73,420
New +$147K ﹤0.01% 566

Other funds holding IBRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return